Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Shared genetic risk locus for central serous chorioretinopathy and varicose veins
Author Affiliations & Notes
  • Joel Rämö
    Helsingin yliopisto Suomen molekyylilaaketieteen instituutti, Helsinki, Uusimaa, Finland
    Broad Institute, Cambridge, Massachusetts, United States
  • Bryan Gorman
    Center for Data and Computational Sciences (C-DACS), VA Cooperative Studies Program, VA Boston Healthcare System, Boston, Massachusetts, United States
    Booz Allen Hamilton Inc, McLean, Virginia, United States
  • Lu-Chen Weng
    Massachusetts General Hospital, Boston, Massachusetts, United States
    Broad Institute, Cambridge, Massachusetts, United States
  • Elon H. C. van Dijk
    Department of Ophthalmology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands
  • Panisa Singhanetr
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Xin Wang
    Broad Institute, Cambridge, Massachusetts, United States
  • Michael B Gorin
    Department of Ophthalmology, UCLA Jules Stein Eye Institute Library, Los Angeles, California, United States
  • Wen-Chih Wu
    Section of Cardiology, Providence VA Medical Center, Providence, Rhode Island, United States
    Department of Medicine, Brown University Warren Alpert Medical School, Providence, Rhode Island, United States
  • Suzanne Yzer
    Radboudumc, Nijmegen, Gelderland, Netherlands
    Radboud Universiteit Donders Institute for Brain Cognition and Behaviour, Nijmegen, Gelderland, Netherlands
  • Neal Peachey
    Research Service, VA Northeast Ohio Healthcare System, Cleveland, Ohio, United States
    Cleveland Clinic Cole Eye Institute, Cleveland Clinic Cole Eye Institute, Cleveland, OH, US, corporate/medprac, Cleveland, Ohio, United States
  • Joni Tururen
    Folkhalsans forskningscentrum, Helsinki, Uusimaa, Finland
    Department of Ophthalmology, Helsingin yliopisto, Helsinki, Uusimaa, Finland
  • Camiel Boon
    Department of Ophthalmology, Amsterdam Universitair Medische Centra, Amsterdam, Noord-Holland, Netherlands
    Department of Ophthalmology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands
  • Patrick Ellinor
    Broad Institute, Cambridge, Massachusetts, United States
    Massachusetts General Hospital, Boston, Massachusetts, United States
  • Mark Daly
    Helsingin yliopisto Suomen molekyylilaaketieteen instituutti, Helsinki, Uusimaa, Finland
    Massachusetts General Hospital, Boston, Massachusetts, United States
  • Sudha K Iyengar
    Research Service, VA Northeast Ohio Healthcare System, Cleveland, Ohio, United States
    Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Elizabeth J Rossin
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Broad Institute, Cambridge, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Joel Rämö None; Bryan Gorman Booz Allen Hamilton, Code E (Employment); Lu-Chen Weng None; Elon van Dijk None; Panisa Singhanetr None; Xin Wang None; Michael Gorin None; Wen-Chih Wu None; Suzanne Yzer None; Neal Peachey NIH Grants P30EY011373 and P30EY025585, Code F (Financial Support), Research to Prevent Blindness, Code F (Financial Support); Joni Tururen None; Camiel Boon None; Patrick Ellinor None; Mark Daly None; Sudha Iyengar Retinal Research Foundation, Code F (Financial Support), NIH Grants P30EY011373 and P30EY025585, Code F (Financial Support), Research to Prevent Blindness, Code F (Financial Support); Elizabeth Rossin None
  • Footnotes
    Support  Fellowship Grant from the Sigrid Jusélius Foundation
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4288. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joel Rämö, Bryan Gorman, Lu-Chen Weng, Elon H. C. van Dijk, Panisa Singhanetr, Xin Wang, Michael B Gorin, Wen-Chih Wu, Suzanne Yzer, Neal Peachey, Joni Tururen, Camiel Boon, Patrick Ellinor, Mark Daly, Sudha K Iyengar, Elizabeth J Rossin; Shared genetic risk locus for central serous chorioretinopathy and varicose veins. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4288.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In a prior genome-wide association study (GWAS) meta-analysis for central serous choroidopathy (CSC), we noted a nominally significant rare variant (P = 8.4e-07) that stood out because of a potential genetic risk overlap with varicose veins. Here, we interrogate this variant in a larger sample (over double the size) for central serous chorioretinopathy to test for definitive evidence of association to both CSC and varicose veins, thus underscoring the mechanistic theory of CSC as a venous overload choroidopathy.

Methods : We first conducted a larger genome-wide association study of CSC including 1,477 patients and 455,449 controls identified using ICD-10 codes from the FinnGen study. These results confirmed a strong association of the rare variant rs113791087 (minor allele frequency = 0.5%) on chromosome 12. Rrs113791087 was the lead variant in the region and lacked convincing nearby tag SNPs. We conducted directed replication in participants of European ancestry in the Million Veteran Program (MVP; 706 ICD-based cases and 273,198 controls) and AllOfUs cohorts (128 ICD-based cases and 114,069 controls), as well as a previously published European dataset of patients with chronic CSC (521 patients and 3,577 controls).

Results : In the discovery cohort, the lead variant rs113791087 was associated with an almost 3-fold increase in the risk of CSC (OR = 2.85; P = 4.5e-9). The effect size was robust to the exclusion of cases and controls with 37 ICD codes reflecting potential confounding causes of fluid maculopathy (OR = 3.15, P = 1.8e-6). Rs113791087 was significantly associated with CSC in all replication cohorts (ORs = 2.21–8.00, P = 0.02–3.0e-9) (Table 1) and a cross-cohort meta-analysis including 2,452 cases and 881,210 controls (OR = 3.06, P = 7.4e-15). In a phenome-wide association study of 2,469 diverse traits in FinnGen, rs113791087 was most significantly associated with varicose veins (38,467 cases and 432,223 controls; OR = 1.39; P = 3.1e-10), and this association replicated in a single-variant analysis of varicose veins in the UK Biobank (OR = 1.22, P = 6.2e-3).

Conclusions : We identify a novel genetic locus with an unusually high odds ratio linking CSC and varicose veins, supporting CSC as a venous overload choroidopathy.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Rs113791087 and risk of central serous chorioretinopathy in different study populations

Rs113791087 and risk of central serous chorioretinopathy in different study populations

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×